GW-311616 is a highly potent, orally bioavailable, and long-acting inhibitor of human neutrophil elastase (HNE), with an IC50 of 22 nM and a Ki of 0.31 nM; it suppresses neutrophil elastase activity, inhibits proliferation, and induces apoptosis in leukemia cells (e.g., U937 and K562 cell lines); it modulates apoptosis-related proteins by upregulating Bax and downregulating Bcl-2; in vivo, it rapidly abolishes circulating neutrophil elastase activity in dogs following oral administration, maintaining >90% inhibition for up to 4 days.